The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Modec Inc
TSE:6269
|
JP |
|
Fevertree Drinks PLC
LSE:FEVR
|
UK |
|
O
|
Opmobility SE
F:EZM
|
FR |
|
Advance ZincTek Ltd
OTC:ADVNF
|
AU |
|
S
|
Sumitomo Corp
F:SUMA
|
JP |
|
Les Hotels Baverez SA
PAR:ALLHB
|
FR |
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
Ceylon Graphite Corp
F:CCY
|
CA |
|
Wall Street Finance Ltd
BSE:511147
|
IN |
|
I
|
Intuit Inc
F:ITU
|
US |
|
Y
|
Yong Shun Chemical Co Ltd
TPEX:4711
|
TW |
|
Joyas International Holdings Ltd
SGX:E9L
|
HK |
|
First National Financial Corp
F:63Z
|
CA |
|
Sartorius AG
XETRA:SRT
|
DE |
|
P
|
Post Holdings Inc
F:2PO
|
US |
|
AAC Clyde Space AB
STO:AAC
|
SE |
|
C
|
Century Aluminum Co
SWB:EY3
|
US |
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
JP |
|
C
|
Chubu Electric Power Co Inc
TSE:9502
|
JP |
|
AAC Technologies Holdings Inc
HKEX:2018
|
KY |
|
G
|
Grupo Supervielle SA
BCBA:SUPV
|
AR |
|
E
|
Equity Residential
LSE:0IIB
|
US |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
|
B
|
Beforepay Group Ltd
ASX:B4P
|
AU |
Modec Inc (6269)’s 12-month stock price forecast through October 2027 has a consensus target of ¥13 005, implying 52% upside. The forecast is based on price targets from 5 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
Modec Inc is 13 005 JPY with a low forecast of 11 817 JPY and a high forecast of 17 850 JPY.
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 444%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 460%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 2 years is 1 725%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 468%.
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is 468%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more